Metabolic Differences That Exist Between Women With and Without Gestational Diabetes Mellitus Twelve Months Following Pregnancy

Overview

Información sobre este estudio

The purpose of this study is to understand the metabolic differences that exist between women with and without Gestational Diabetes Mellitus (GDM) 12 months following pregnancy to help us clarify why women with GDM are at higher risk of type 2 diabetes.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Subjects will be recruited 1 year from their most recent live birth.
  • 30 with Gestational Diabetes Mellitus (GDM) in the preceding pregnancy.
  • 30 with no history of GDM.

Exclusion Criteria: 

  • Individuals < 20 or > 40 years at the preceding pregnancy.
  • Active systemic illness.
  • Preceding multiple gestation pregnancy.
  • Taking medication that affects glucose metabolism.
  • Upper GI surgery that alters gastric emptying.
  • Current BM I< 25kg/m^2.
  • For the GDM group, those with GDM in any pregnancy prior to the most recent pregnancy will be excluded (to reduce within group heterogeneity).
  • Currently pregnant or breastfeeding. At a screening visit, subjects will provide consent and undergo a history and physical. They will have an EKG, blood draw for complete blood count, fasting glucose, HbA1c and chemistry group, and a pregnancy test. Subjects will be excluded if HbA1c is > 5.6% or fasting glucose is > 100mg/dL. Body composition will be measured using dual-energy X-ray absorptiometry (iDXA scanner; GE Wauwatosa, WI).

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 4/18/23. Questions regarding updates should be directed to the study team contact.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Aoife Egan, M.B., B.Ch., Ph.D.

Abierto para la inscripción

Contact information:

Aoife Egan M.B., B.Ch., Ph.D.

(507) 284-4080

Egan.Aoife@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20557283

Mayo Clinic Footer